Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Pharma
Xspray's Dasynoc knocked back by FDA over production once again
Less than a year after the FDA turned down the filing for its leukemia prospect Dasynoc, Xspray Pharma has again hit a wall at the U.S. regulator.
Fraiser Kansteiner
Aug 20, 2026 2:50pm
Aurinia deal with Teva keeps Lupkynis generic in check until '36
Aug 20, 2026 11:28am
How AI, Creativity and Commercialization Are Converging
Brought to you by
EVERSANA INTOUCH
B. Braun launches IV solution recall over particle concerns
Aug 20, 2026 10:44am
Designing an agentic, future‑ready tech roadmap for emerging pharma
Brought to you by
ZS
UK cost watchdog endorses Lilly's weekly insulin injectable
Aug 20, 2026 9:12am
